Everything below concerns LC-MS/MS. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-03-09. Numbers and descriptions here follow the published literature rather than marketing material.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic small-molecule REV-ERB agonist | Not a hormone or natural product |
| Primary targets | REV-ERBα and REV-ERBβ | Nuclear receptors involved in circadian and metabolic regulation |
| Appearance | White to off-white solid | Typical for purified research samples |
| Solubility | Soluble in DMSO and ethanol; low water solubility | Laboratory solubility depends on solvent and purity |
| Common synonyms | SR9009; Stenabolic | Stenabolic is a colloquial name, not a formal chemical name |
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.
In pharmacology, relative bioavailability measures the bioavailability (estimated as the AUC) of a formulation (A) of a certain drug when compared with another formulation (B) of the same drug, usually an established standard, or through administration via a different route. When the standard consists of intravenously administered drug, this is known as absolute bioavailability (see above). F r e l = 100 ⋅ A U C A ⋅ D B A U C B ⋅ D A {\displaystyle F_{\mathrm {rel} }=100\cdot {\frac {AUC_{\mathrm {A} }\cdot D_{\mathrm {B} }}{AUC_{\mathrm {B} }\cdot D_{\mathrm {A} }}}}
Contributions to island of inversion measurements and potential discovery of new magic numbers The island of inversion is a region of the chart of nuclides in which isotopes have enhanced stability, compared to the surrounding unstable nuclei. The island is associated with the magic neutron numbers (N = 8, 14, 20, 28, 50, 82, 126), where this breakdown occurs. Various experiments at ISOLDE have determined properties of these island of inversion isotopes, including the first of their kind measurements performed with Miniball on magnesium-32, lying in the island of inversion at N = 20. Furthermore, the ISOLTRAP experiment provided results using calcium-52 to reveal a potential new magic number, 32, which was later disproven by the CRIS experiment. Production of isomeric beams A nuclear isomer is a metastable state of a nucleus, in which one or more nucleons occupy higher energy levels than in the ground state of the same nucleus. In the mid-2000s, REX-ISOLDE developed a technique to select and post-accelerate isomeric beams to use in nuclear-decay experiments, such as at Miniball.
Tuberculin/PPD is injected into the skin for the tuberculin skin test. After some time the amount of swelling is measured to determine the immune system's current level of activity against tuberculosis. A high level of swelling is considered proof for tuberculosis infection. The currently globally accepted method is the Mantoux test, named after French physician Charles Mantoux who pioneered using such a test in 1907. However, this test was not reliable enough until the replacement of crude tuberculin by PPD in the 1940s. In the Mantoux test, the swelling is measured after 48 to 72 hours. If the area has a diameter more than a five to ten millimeters of swelling, the test is considered positive. Reliable administration of the skin test requires large amounts of training, supervision, and practice. The test may be falsely positive in those who have been previously vaccinated with BCG or have been infected by other types of mycobacteria. The test may be falsely negative within ten weeks of infection, in those less than six months old, and in those who have been infected for many years. Alternative skin test methods include:
=== Hormonal regulation of bone formation and serum levels === Parathyroid hormone and vitamin D promote the formation of bone by allowing and enhancing the deposition of calcium ions there, allowing rapid bone turnover without affecting bone mass or mineral content. When plasma calcium levels fall, cell surface receptors are activated and the secretion of parathyroid hormone occurs; it then proceeds to stimulate the entry of calcium into the plasma pool by taking it from targeted kidney, gut, and bone cells, with the bone-forming action of parathyroid hormone being antagonised by calcitonin, whose secretion increases with increasing plasma calcium levels.
Pituitary adenylate cyclase-activating polypeptide type 1 receptor InterPro: IPR002285 PACAPR (ADCYAP1R1) Calcitonin receptor InterPro: IPR003287 CALCR Calcitonin receptor-like receptor InterPro: IPR015476 CALCRL Corticotropin-releasing hormone receptor InterPro: IPR003051 CRHR1; CRHR2 Glucose-dependent insulinotropic polypeptide receptor/Gastric inhibitory polypeptide receptor InterPro: IPR001749 GIPR Glucagon receptor InterPro: IPR003291 GCGR Glucagon receptor-related InterPro: IPR003290 GLP1R; GLP2R; Growth hormone releasing hormone receptor InterPro: IPR003288 GHRHR Parathyroid hormone receptor InterPro: IPR002170 PTHR1; PTHR2 Secretin receptor InterPro: IPR002144 SCTR Vasoactive intestinal peptide receptor InterPro: IPR001571 VIPR1; VIPR2
Sources: en.wikipedia.org
In 1906, Hahn returned to Germany, where Fischer placed at his disposal a former woodworking shop (Holzwerkstatt) in the basement of the Chemical Institute to use as a laboratory. Hahn equipped it with electroscopes to measure alpha and beta particles and gamma rays. In Montreal these had been made from discarded coffee tins; Hahn made the ones in Berlin from brass, with aluminium strips insulated with amber. These were charged with hard rubber sticks that he rubbed against the sleeves of his suit. It was not possible to conduct research in the wood shop, but Alfred Stock, the head of the inorganic chemistry department, let Hahn use a space in one of his two private laboratories. Hahn purchased two milligrams of radium from Friedrich Oskar Giesel, the discoverer of emanium (radon), for 100 marks a milligram (equivalent to €700 in 2021), and obtained thorium for free from Otto Knöfler, whose Berlin firm was a major producer of thorium products. In the space of a few months Hahn discovered mesothorium I (radium-228), mesothorium II (actinium-228), and – independently from Boltwood – the mother substance of radium, ionium (later identified as thorium-230). In subsequent years, mesothorium I assumed great importance because, like radium-226 (discovered by Pierre and Marie Curie), it was ideally suited for use in medical radiation treatment, but cost only half as much to manufacture. Along the way, Hahn determined that just as he was unable to separate thorium from radiothorium, so he could not separate mesothorium I from radium.
== Risk of injury == Injuries can happen in activities like yoga and aerobics . Quick, ballistic stretching can cause injury if it is done incorrectly. If a bone, muscle, or any other part is stretched more than its capacity, it may lead to dislocation or muscle pulls. Overstretching can increase chances of injury by stretching the muscle too much. Overstretching could lead to a sprain or strain, which requires rest or even physical therapy to recover from.
=== Active regions === A model based on electron crystallographic density and nuclear magnetic resonance deconvolution has been proposed to explain the binding of docetaxel to β-tubulin. In this T-shaped/butterfly model, a deep hydrophobic cleft exists near the surface of the β-tubulin where three potential hydrogen bonds and multiple hydrophobic contacts bind to docetaxel. The hydrophobic pocket walls contain helices H1, H6, H7 and a loop between H6 and H7 that form hydrophobic interactions with the 3'-benzamido phenyl, 3'-phenyl, and the 2-benzoyl phenyl of docetaxel. 3'-phenyl also has contact with β-sheets B8 and B10. The C-8 methyl of docetaxel has Van der Waals interactions with two residues, Thr-276 and Gln-281 near the C-terminal end of β-tubulin. Docetaxel's O-21 experiences electrostatic attraction to Thr-276 and the C-12 methyl has proximity with Leu-371 on the loop between B9 and B10.
Hypercalcemia and/or hypercalciuria reflect the known pharmacodynamic actions of parathyroid hormone in the gastrointestinal tract, the kidney and the skeleton, and is therefore an expected undesirable effect. Nausea is another commonly reported adverse reaction to the use of parathyroid hormone.
Sources: en.wikipedia.org
=== Prediction of co-evolved protein pairs based on similar phylogenetic trees === It was observed that the phylogenetic trees of ligands and receptors were often more similar than due to random chance. This is likely because they faced similar selection pressures and co-evolved. This method uses the phylogenetic trees of protein pairs to determine if interactions exist. To do this, homologs of the proteins of interest are found (using a sequence search tool such as BLAST) and multiple-sequence alignments are done (with alignment tools such as Clustal) to build distance matrices for each of the proteins of interest. The distance matrices should then be used to build phylogenetic trees. However, comparisons between phylogenetic trees are difficult, and current methods circumvent this by simply comparing distance matrices. The distance matrices of the proteins are used to calculate a correlation coefficient, in which a larger value corresponds to co-evolution. The benefit of comparing distance matrices instead of phylogenetic trees is that the results do not depend on the method of tree building that was used. The downside is that difference matrices are not perfect representations of phylogenetic trees, and inaccuracies may result from using such a shortcut. Another factor worthy of note is that there are background similarities between the phylogenetic trees of any protein, even ones that do not interact. If left unaccounted for, this could lead to a high false-positive rate.
A sex pheromone released by male mealworm beetles has been identified. Inbreeding reduces the attractiveness of sexual pheromone signaling by male mealworm beetles. Females are more attracted to the odors produced by outbred males than the odors produced by inbred males. The reduction of male signaling capability may be due to increased expression of homozygous deleterious recessive alleles, caused by inbreeding. The mealworm beetle breeds prolifically. Males insert sperm packets with their aedeagus. Within a few days, the female burrows into soft ground and lays eggs. Over her adult lifespan of about 6–12 months, a female will, on average, lay about 500 eggs.
Levels of testosterone have been found to increase 1.5- to 2-fold (59–97% increase) and levels of estradiol about 1.5- to 2.5-fold (65–146% increase) in men treated with 150 mg/day bicalutamide monotherapy. In addition to testosterone and estradiol, there are smaller increases in concentrations of DHT, sex hormone-binding globulin, and prolactin. Estradiol levels with bicalutamide monotherapy are similar to those in the low-normal premenopausal female range while testosterone levels generally remain in the high end of the normal male range. Testosterone concentrations do not typically exceed the normal male range due to negative feedback on the HPG axis by the increased concentrations of estradiol. Bicalutamide influences the HPG axis and increases hormone levels only in men and not also in women. This is due to the much lower levels of androgens in women and their lack of basal suppression of the HPG axis in this sex. As evidenced by its effectiveness in the treatment of prostate cancer and other androgen-dependent conditions, the antiandrogenic actions of bicalutamide considerably exceed any impact of the increased levels of testosterone it results in. However, the elevated levels of estradiol remain unopposed by bicalutamide and are responsible for the gynecomastia and feminizing side effects it causes in men.
Sources: en.wikipedia.org
It is a synthetic research compound that activates REV-ERB nuclear receptors. It is not an approved drug or dietary supplement. Most information comes from cell and animal studies.
It binds REV-ERBα and REV-ERBβ and changes transcription of metabolic genes. This can affect circadian rhythm, lipid use, and mitochondrial function. The full downstream effects are still under study.
No. Some rodent studies show increased endurance, but controlled human trials are lacking. Claims about human performance are not established by published evidence.
The most common approach is liquid chromatography-tandem mass spectrometry, often after extraction from blood, urine, or tissue. Ultraviolet detection and nuclear magnetic resonance spectroscopy are used mainly for reference material characterization. Isotope-labeled internal standards improve accuracy.